2016-06-02 15:38
Hundreds of billions of market straight companies have Nuggets genetic testing＂
Direct reporting network in Beijing in May 31st (first direct network) in June 2000 the completion of the gene map published in the meeting, Clinton said: This is the language used by God to create life". And now we are beginning to understand the language of God. In early 2015, the United States Obama government promulgated the precise medical plan, in March this year, the Ministry of science and technology will also be included in key research and development of precision medical plans, precise medical attention by the governments of China and the United States attaches great importance to. As the vanguard of the precise medical gene was also academic, capital and industry concerns.
It can be predicted that the market ushered in the outbreak of genetic testing. Many straight enterprises also saw the trend, sansei, ShuangDi, as new enterprises have been involved in genetic testing, will use in their own products and industrial practice.
Global gene detection will reach 100 billion market size
According to iResearch finishing public data shows, the market size of the global gene sequencing showed a trend of increased year by year, in 2007 global gene sequencing market size for $7.9 billion and $54.5 billion market in 2014 is expected to 2018 global gene sequencing market size will exceed $110 billion, the annual compound growth rate of 21.1%.
With the maturity of gene sequencing technology, the cost of gene sequencing is decreasing year by year, the decline in the cost of sequencing will increase the permeability of gene sequencing services, and thus promote the development of the market. Gene sequencing needs to grow at the same time, but also increased the demand for gene sequencing supplies and reagents, so in the growth of gene sequencing services at the same time, but also led to the growth of sequencing supplies and reagents.
In March this year, China's Ministry of science and Technology launched the China precision medical program. Plans to put forward, by 2030, China will invest 60 billion yuan in the field of precision medical. The industry believes that genetic testing is already "early spring" in March, will be the next two or three years a comprehensive outbreak. The outbreak of the "equivalent" in the end how much the medical profession's prediction is - one hundred billion.
A precise role of health - gene detection
According to the tradition of the Internet industry track selection standard and gene sequencing industry growth is only 20%, does not belong to quality track, but the investment in the field of the fiery concern, that gene sequencing only is the foundation and the subsequent leveraging the size of the market is extremely large.
Genetic testing in a large health industry layout three, plays a role of a crowbar. In May this year, three released a comprehensive upgrade strategy and business model in the 2016 Carnival celebrations. One of the biggest bright spot is the precise health".
Precision health has become a benchmark for the future of major health industry. In order to achieve precise health, the emerging gene industry is the global rise, and will become a breakthrough in the bio economy. Sansheng grasp gene the commanding height of the market, for the user to provide ecological life quality management at the same time, grasp the market of genetic testing of hundreds of millions of business opportunities.
Accurate detection is Sansheng company to do the first ring, why to do genetic testing, gene is one of life's basic information, the future will be won't get sick, what disease? Children have any talents? These through genetic testing are predictable. The future, sansei will build a covers gene detection, nursed back to health, risk prevention, medical rehabilitation for one of the whole ecosystem health industrial clusters, for consumers and partners provide comprehensive health life solutions.
Precise anti-aging - the amount of skin customized gene chip
Gene testing is not only used in medical care, health care, but also for skin care.
As has been to science and technology to lead the innovation for the enterprise development concepts such as the new, ageLOC innovative anti-aging technology was born, the human skin in-depth studies of gene and a across: find the impact of human aging youth gene group, and through the gene chip and gene expression of thermal spectra selected for the components and adjust the grouping of genes expression, and eventually through scientific formula R & D ageLOC products series, injected more vitality to the skin a healthy, youthful.
It is worth mentioning that, NUSKIN new initiatives such as the new breakthrough in the field of precision based on biological gene technology precision. It is reported that, NUSKIN new research and development of new products, such as ageLOCMe, is a set of advanced science and technology, a large database of genes and professional anti-aging program as one of the intelligent private skin care instrument. According to the new research team revealed that the development of the product after 27 billion times the precise calculation, the 8500 formulation of the test, and obtained a number of patent applications.
It is understood, new ageLOC me wisdom I skin management system, the integration of cutting-edge technology and breakthrough anti-aging formula, containing a ageLOC me new wisdom I skin management intelligent instrument and five precision special benchmark core intellectual, with "one exclusive machine a code, an app account management" ageLOC me new wisdom my skin evaluation software, based on individual skin evaluation results custom formulations code, "customize the amount of skin". Use, only need to easily reach out, you will be able to get the exclusive formula for the aging of the individual, not only fresh, but also vacuum preservation, intelligent, convenient, environmentally friendly.
Quest DNA -- the establishment of medical high precision platform
Different from juniors and Nu Skin, a lot of ShuangDi start and no gene was detected from the start, but gene is composed of a material -- the study of nucleic acid from the start. DNA is made up of a certain sequence of nucleic acids, and the gene is a specific sequence of nucleic acids on the DNA. Dalian ShuangDi over the years has been on nucleic acid source of nutrients used in the promotion of human medical, health, health care, nutrition.
ShuangDi, founder and CEO Chen Yusong, because he used to be a nucleic acid, because DNA founded the Austrian and ShuangDi enterprises. In 1992 he made a margin with the nucleic acid, "nucleic acid into my life, into my career, to become my life DNA, to become the cause of DNA."
At present, genetic testing has been a part of the strategic planning of shuangdi. Companies in the direct selling business strategic planning mentions, and strive to 5 years to create tens of billions of enterprise, go hand in hand in the insurance, finance, genetic testing, health management sector, realize the fission development capital.
ShuangDi shares also have a special gene detection mechanism -- Jingtai medical examination. Dalian Jingtai Biological Technology Co., Ltd. is Jane Xinao group, a subsidiary, is a gene technology as the core, to genetic testing and high-throughput sequencing as the leading R & D, production, scientific research and medical testing in one of the high-tech enterprises. Company under the Dalian Jing Tai medical laboratory, mainly engaged in DNA test, designed to be used in the prediction of medical, disease diagnosis, health management, personalized medical services, etc., to carry out special medical diagnostic services.
By ShuangDi shares, Jane Xinao group, Dalian Baiao Tai jointly hosted the Seventh International DNA and genome activity was held April 25-28, 2016. Through the forum, experts gathered Gonghua gene, discussed the prospects for the development of precise medical industry, the exchange of the latest developments in detection technology and platform, to lead the new direction of the development of genetic tests, establish precise medical high platform to the important role in promoting, ShuangDi is actively developing gene to detect the cause of injected new scientific strength.
Chinese gene testing market is far from outbreak
Although genetic testing market prospects, but at this stage the gene sequencing industry is far from being the Internet Medical hot industry.
The cost of gene sequencing still is higher than that of other alternative detection, is the present stage China gene sequencing industry generally do not have favorable capital market is one of the main reasons, the prenatal examination, for example, no invasive prenatal genetic monitoring cost in 2000-3000 yuan, while the amniotic fluid puncture cost 700 yuan the left and right. Another important reason is that the current application of genetic testing is not rich enough, at this stage, the direction of the application is mainly scientific research and clinical medicine two directions.
However, the outbreak of genetic testing market is the trend. At present, genetic testing is on the rise, and it can be expected that the future will bring great benefits to the whole human society. "Genetic testing" will be in the next few years a comprehensive outbreak. And direct enterprises to do a good job of genetic testing, it is necessary to grasp the commanding heights of the gene market, grasp the future business opportunities in the gene detection market.
Interpretation of the news hot spots, showing sensitive events, more exclusive analysis, in the "things" WeChat, scan two-dimensional code free reading.
|